Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Obsessive compulsive disorder with and without hoarding symptoms: Characterizing differences.

Boerema YE, de Boer MM, van Balkom AJLM, Eikelenboom M, Visser HA, van Oppen P.

J Affect Disord. 2019 Mar 1;246:652-658. doi: 10.1016/j.jad.2018.12.115. Epub 2018 Dec 27.

PMID:
30611063
2.

Comparing factor structures of depressed patients with and without suicidal ideation, a measurement invariance analysis.

van Ballegooijen W, Eikelenboom M, Fokkema M, Riper H, van Hemert AM, Kerkhof AJFM, Penninx BWJH, Smit JH.

J Affect Disord. 2019 Feb 15;245:180-187. doi: 10.1016/j.jad.2018.10.108. Epub 2018 Oct 17.

PMID:
30396056
3.

Feasibility and impact of data-driven learning within the suicide prevention action network of thirteen specialist mental healthcare institutions (SUPRANET Care) in the Netherlands: a study protocol.

Setkowski K, Mokkenstorm J, van Balkom AJ, Franx G, Verbeek-van Noord I, Dongelmans DA, Eikelenboom M, Gilissen R.

BMJ Open. 2018 Aug 20;8(8):e024398. doi: 10.1136/bmjopen-2018-024398.

4.

A 6-year longitudinal study of predictors for suicide attempts in major depressive disorder.

Eikelenboom M, Beekman ATF, Penninx BWJH, Smit JH.

Psychol Med. 2019 Apr;49(6):911-921. doi: 10.1017/S0033291718001423. Epub 2018 Jun 13.

PMID:
29897037
5.

Incidence and outcome of acquired demyelinating syndromes in Dutch children: update of a nationwide and prospective study.

de Mol CL, Wong YYM, van Pelt ED, Ketelslegers IA, Bakker DP, Boon M, Braun KPJ, van Dijk KGJ, Eikelenboom MJ, Engelen M, Geleijns K, Haaxma CA, Niermeijer JMF, Niks EH, Peeters EAJ, Peeters-Scholte CMPCD, Poll-The BT, Portier RP, de Rijk-van Andel JF, Samijn JPA, Schippers HM, Snoeck IN, Stroink H, Vermeulen RJ, Verrips A, Visscher F, Vles JSH, Willemsen MAAP, Catsman-Berrevoets CE, Hintzen RQ, Neuteboom RF.

J Neurol. 2018 Jun;265(6):1310-1319. doi: 10.1007/s00415-018-8835-6. Epub 2018 Mar 22.

6.

Attempted suicide of ethnic minority girls with a Caribbean and Cape Verdean background: rates and risk factors.

van Bergen DD, Eikelenboom M, van de Looij-Jansen PP.

BMC Psychiatry. 2018 Jan 17;18(1):14. doi: 10.1186/s12888-017-1585-7.

7.

Chronic obsessive-compulsive disorder: prognostic factors.

van Oudheusden LJB, Eikelenboom M, van Megen HJGM, Visser HAD, Schruers K, Hendriks GJ, van der Wee N, Hoogendoorn AW, van Oppen P, van Balkom AJLM.

Psychol Med. 2018 Oct;48(13):2213-2222. doi: 10.1017/S0033291717003701. Epub 2018 Jan 9.

PMID:
29310732
8.

The relationship between cognitions and symptoms in obsessive-compulsive disorder.

Tibi L, van Oppen P, van Balkom AJLM, Eikelenboom M, Hendriks GJ, Anholt GE.

J Affect Disord. 2018 Jan 1;225:495-502. doi: 10.1016/j.jad.2017.08.072. Epub 2017 Aug 30.

PMID:
28865371
9.

The long-term association of OCD and depression and its moderators: A four-year follow up study in a large clinical sample.

Tibi L, van Oppen P, van Balkom AJLM, Eikelenboom M, Rickelt J, Schruers KRJ, Anholt GE.

Eur Psychiatry. 2017 Jul;44:76-82. doi: 10.1016/j.eurpsy.2017.03.009. Epub 2017 Apr 7.

PMID:
28545012
10.

Evaluation of the 113Online Suicide Prevention Crisis Chat Service: Outcomes, Helper Behaviors and Comparison to Telephone Hotlines.

Mokkenstorm JK, Eikelenboom M, Huisman A, Wiebenga J, Gilissen R, Kerkhof AJFM, Smit JH.

Suicide Life Threat Behav. 2017 Jun;47(3):282-296. doi: 10.1111/sltb.12286. Epub 2016 Aug 19.

PMID:
27539122
11.

The relation between depressive and obsessive-compulsive symptoms in obsessive-compulsive disorder: Results from a large, naturalistic follow-up study.

Rickelt J, Viechtbauer W, Lieverse R, Overbeek T, van Balkom AJ, van Oppen P, van den Heuvel OA, Marcelis M, Eikelenboom M, Tibi L, Schruers KR.

J Affect Disord. 2016 Oct;203:241-247. doi: 10.1016/j.jad.2016.06.009. Epub 2016 Jun 6.

PMID:
27310102
12.

Inference-Based Approach versus Cognitive Behavioral Therapy in the Treatment of Obsessive-Compulsive Disorder with Poor Insight: A 24-Session Randomized Controlled Trial.

Visser HA, van Megen H, van Oppen P, Eikelenboom M, Hoogendorn AW, Kaarsemaker M, van Balkom AJ.

Psychother Psychosom. 2015;84(5):284-93. doi: 10.1159/000382131. Epub 2015 Aug 6.

PMID:
26278470
13.

Longitudinal Associations Between Biopsychosocial Factors and Sustainable Return to Work of Sick-Listed Workers with a Depressive or Anxiety Disorder.

Lammerts L, Schaafsma FG, Eikelenboom M, Vermeulen SJ, van Mechelen W, Anema JR, Penninx BW.

J Occup Rehabil. 2016 Mar;26(1):70-9. doi: 10.1007/s10926-015-9588-z.

14.

The relationship between adverse childhood experiences and symptom severity, chronicity, and comorbidity in patients with obsessive-compulsive disorder.

Visser HA, van Minnen A, van Megen H, Eikelenboom M, Hoogendoorn AW, Kaarsemaker M, van Balkom AJ, van Oppen P.

J Clin Psychiatry. 2014 Oct;75(10):1034-9. doi: 10.4088/JCP.13m08825.

PMID:
25006863
15.

Reporting suicide attempts: consistency and its determinants in a large mental health study.

Eikelenboom M, Smit JH, Beekman AT, Kerkhof AJ, Penninx BW.

Int J Methods Psychiatr Res. 2014 Jun;23(2):257-66. doi: 10.1002/mpr.1423. Epub 2014 Feb 25.

PMID:
24615804
16.

Childhood lymphomatoid granulomatosis: a report of 2 cases and review of the literature.

Tacke ZC, Eikelenboom MJ, Vermeulen RJ, van der Knaap MS, Euser AM, van der Valk P, Kaspers GJ.

J Pediatr Hematol Oncol. 2014 Oct;36(7):e416-22. doi: 10.1097/MPH.0000000000000090. Review.

PMID:
24390446
17.

Obsessive-compulsive disorder; chronic versus non-chronic symptoms.

Visser HA, van Oppen P, van Megen HJ, Eikelenboom M, van Balkom AJ.

J Affect Disord. 2014 Jan;152-154:169-74. doi: 10.1016/j.jad.2013.09.004. Epub 2013 Sep 13.

PMID:
24084621
18.

Recurrent suicide attempts in patients with depressive and anxiety disorders: the role of borderline personality traits.

Stringer B, van Meijel B, Eikelenboom M, Koekkoek B, Licht CM, Kerkhof AJ, Penninx BW, Beekman AT.

J Affect Disord. 2013 Oct;151(1):23-30. doi: 10.1016/j.jad.2013.02.038. Epub 2013 Apr 25.

19.

Age of onset in obsessive-compulsive disorder: admixture analysis with a large sample.

Anholt GE, Aderka IM, van Balkom AJ, Smit JH, Schruers K, van der Wee NJ, Eikelenboom M, De Luca V, van Oppen P.

Psychol Med. 2014 Jan;44(1):185-94. doi: 10.1017/S0033291713000470. Epub 2013 Mar 21.

PMID:
23517651
20.

Perceived need for care and health care utilization among depressed and anxious patients with and without suicidal ideation.

Stringer B, van Meijel B, Eikelenboom M, Koekkoek B, Verhaak PF, Kerkhof AJ, Penninx BW, Beekman AT.

Crisis. 2013;34(3):192-9. doi: 10.1027/0227-5910/a000182.

PMID:
23261915
21.

The Netherlands Obsessive Compulsive Disorder Association (NOCDA) study: design and rationale of a longitudinal naturalistic study of the course of OCD and clinical characteristics of the sample at baseline.

Schuurmans J, van Balkom AJ, van Megen HJ, Smit JH, Eikelenboom M, Cath DC, Kaarsemaker M, Oosterbaan D, Hendriks GJ, Schruers KR, van der Wee NJ, Glas G, van Oppen P.

Int J Methods Psychiatr Res. 2012 Dec;21(4):273-85. doi: 10.1002/mpr.1372. Epub 2012 Nov 12.

PMID:
23148029
22.

Cognitive therapy versus fluvoxamine as a second-step treatment in obsessive-compulsive disorder nonresponsive to first-step behavior therapy.

van Balkom AJ, Emmelkamp PM, Eikelenboom M, Hoogendoorn AW, Smit JH, van Oppen P.

Psychother Psychosom. 2012;81(6):366-74. doi: 10.1159/000339369. Epub 2012 Sep 6.

23.

Incidence of acquired demyelinating syndromes of the CNS in Dutch children: a nationwide study.

Ketelslegers IA, Catsman-Berrevoets CE, Neuteboom RF, Boon M, van Dijk KG, Eikelenboom MJ, Gooskens RH, Niks EH, Overweg-Plandsoen WC, Peeters EA, Peeters-Scholte CM, Poll-The BT, de Rijk-van Andel JF, Samijn JP, Snoeck IN, Stroink H, Vermeulen RJ, Verrips A, Vles JS, Willemsen MA, Rodrigues Pereira R, Hintzen RQ.

J Neurol. 2012 Sep;259(9):1929-35. doi: 10.1007/s00415-012-6441-6. Epub 2012 Feb 17.

24.

Do depression and anxiety converge or diverge in their association with suicidality?

Eikelenboom M, Smit JH, Beekman AT, Penninx BW.

J Psychiatr Res. 2012 May;46(5):608-15. doi: 10.1016/j.jpsychires.2012.01.025. Epub 2012 Feb 15.

PMID:
22340981
25.

Blood and CSF Biomarker Dynamics in Multiple Sclerosis: Implications for Data Interpretation.

Eikelenboom MJ, Uitdehaag BM, Petzold A.

Mult Scler Int. 2011;2011:823176. doi: 10.1155/2011/823176. Epub 2011 Apr 14.

26.

Normal CSF ferritin levels in MS suggest against etiologic role of chronic venous insufficiency.

Worthington V, Killestein J, Eikelenboom MJ, Teunissen CE, Barkhof F, Polman CH, Uitdehaag BM, Petzold A.

Neurology. 2010 Nov 2;75(18):1617-22. doi: 10.1212/WNL.0b013e3181fb449e. Epub 2010 Sep 29.

PMID:
20881272
27.

Suicidal behavior and ethnicity of young females in Rotterdam, The Netherlands: rates and risk factors.

van Bergen DD, Eikelenboom M, Smit JH, van de Looij-Jansen PM, Saharso S.

Ethn Health. 2010 Oct;15(5):515-30. doi: 10.1080/13557858.2010.494719.

PMID:
20694868
28.

Cerebrospinal fluid ATP metabolites in multiple sclerosis.

Lazzarino G, Amorini AM, Eikelenboom MJ, Killestein J, Belli A, Di Pietro V, Tavazzi B, Barkhof F, Polman CH, Uitdehaag BM, Petzold A.

Mult Scler. 2010 May;16(5):549-54. doi: 10.1177/1352458510364196. Epub 2010 Mar 1.

PMID:
20194579
29.

Autism and ADHD symptoms in patients with OCD: are they associated with specific OC symptom dimensions or OC symptom severity?

Anholt GE, Cath DC, van Oppen P, Eikelenboom M, Smit JH, van Megen H, van Balkom AJ.

J Autism Dev Disord. 2010 May;40(5):580-9. doi: 10.1007/s10803-009-0922-1.

30.

Fatigue and depression in children with multiple sclerosis and monophasic variants.

Ketelslegers IA, Catsman-Berrevoets CE, Boon M, Eikelenboom MJ, Stroink H, Neuteboom RF, Aarsen FK, van de Putte EM, Hintzen RQ.

Eur J Paediatr Neurol. 2010 Jul;14(4):320-5. doi: 10.1016/j.ejpn.2009.09.004. Epub 2009 Oct 12.

PMID:
19822449
31.

Implementation of outpatient schema therapy for borderline personality disorder: study design.

Nadort M, Arntz A, Smit JH, Giesen-Bloo J, Eikelenboom M, Spinhoven P, van Asselt T, Wensing M, van Dyck R.

BMC Psychiatry. 2009 Oct 6;9:64. doi: 10.1186/1471-244X-9-64.

32.

Implementation of outpatient schema therapy for borderline personality disorder with versus without crisis support by the therapist outside office hours: A randomized trial.

Nadort M, Arntz A, Smit JH, Giesen-Bloo J, Eikelenboom M, Spinhoven P, van Asselt T, Wensing M, van Dyck R.

Behav Res Ther. 2009 Nov;47(11):961-73. doi: 10.1016/j.brat.2009.07.013. Epub 2009 Jul 14.

PMID:
19698939
33.

Three preparatory studies for promoting implementation of outpatient schema therapy for borderline personality disorder in general mental health care.

Nadort M, van Dyck R, Smit JH, Giesen-Bloo J, Eikelenboom M, Wensing M, Spinhoven P, Dirksen C, Bleecke J, van Milligen B, van Vreeswijk M, Arntz A.

Behav Res Ther. 2009 Nov;47(11):938-45. doi: 10.1016/j.brat.2009.07.004. Epub 2009 Aug 18.

PMID:
19691953
34.

Gender differences in multiple sclerosis: cytokines and vitamin D.

Eikelenboom MJ, Killestein J, Kragt JJ, Uitdehaag BM, Polman CH.

J Neurol Sci. 2009 Nov 15;286(1-2):40-2. doi: 10.1016/j.jns.2009.06.025. Epub 2009 Aug 4. Review.

PMID:
19656528
35.

N-acetylaspartic acid in cerebrospinal fluid of multiple sclerosis patients determined by gas-chromatography-mass spectrometry.

Jasperse B, Jakobs C, Eikelenboom MJ, Dijkstra CD, Uitdehaag BM, Barkhof F, Polman CH, Teunissen CE.

J Neurol. 2007 May;254(5):631-7. Epub 2007 Apr 6.

36.

The new global multiple sclerosis severity score (MSSS) correlates with axonal but not glial biomarkers.

Petzold A, Eikelenboom MI, Keir G, Polman CH, Uitdehaag BM, Thompson EJ, Giovannoni G.

Mult Scler. 2006 Jun;12(3):325-8.

PMID:
16764346
37.

Brain atrophy and lesion load as explaining parameters for cognitive impairment in multiple sclerosis.

Lazeron RH, Boringa JB, Schouten M, Uitdehaag BM, Bergers E, Lindeboom J, Eikelenboom MI, Scheltens PH, Barkhof F, Polman CH.

Mult Scler. 2005 Oct;11(5):524-31.

PMID:
16193889
38.

Sex differences in proinflammatory cytokine profiles of progressive patients in multiple sclerosis.

Eikelenboom MJ, Killestein J, Uitdehaag BM, Polman CH.

Mult Scler. 2005 Oct;11(5):520-3.

PMID:
16193888
39.

Axonal damage accumulates in the progressive phase of multiple sclerosis: three year follow up study.

Petzold A, Eikelenboom MJ, Keir G, Grant D, Lazeron RH, Polman CH, Uitdehaag BM, Thompson EJ, Giovannoni G.

J Neurol Neurosurg Psychiatry. 2005 Feb;76(2):206-11.

40.

Expression of adhesion molecules on peripheral lymphocytes predicts future lesion development in MS.

Eikelenboom MJ, Killestein J, Izeboud T, Kalkers NF, Baars PA, van Lier RA, Barkhof F, Uitdehaag BM, Polman CH.

J Neuroimmunol. 2005 Jan;158(1-2):222-30.

PMID:
15589057
41.

CSF nitric oxide metabolites are associated with activity and progression of multiple sclerosis.

Rejdak K, Eikelenboom MJ, Petzold A, Thompson EJ, Stelmasiak Z, Lazeron RH, Barkhof F, Polman CH, Uitdehaag BM, Giovannoni G.

Neurology. 2004 Oct 26;63(8):1439-45.

PMID:
15505162
42.

Opticospinal multiple sclerosis: a pathogenetically distinct form?

Eikelenboom MJ, Killestein J, Uitdehaag BM, Polman CH.

Mult Scler. 2004 Jun;10(3):334-5. No abstract available.

PMID:
15222703
43.

Oligoclonal immunoglobulins in cerebrospinal fluid during varicella zoster virus (VZV) vasculopathy are directed against VZV.

Burgoon MP, Hammack BN, Owens GP, Maybach AL, Eikelenboom MJ, Gilden DH.

Ann Neurol. 2003 Oct;54(4):459-63.

44.

Cytokine producing CD8+ T cells are correlated to MRI features of tissue destruction in MS.

Killestein J, Eikelenboom MJ, Izeboud T, Kalkers NF, Adèr HJ, Barkhof F, Van Lier RA, Uitdehaag BM, Polman CH.

J Neuroimmunol. 2003 Sep;142(1-2):141-8.

PMID:
14512173
45.

One year changes in disability in multiple sclerosis: neurological examination compared with patient self report.

Hoogervorst EL, Eikelenboom MJ, Uitdehaag BM, Polman CH.

J Neurol Neurosurg Psychiatry. 2003 Apr;74(4):439-42. Erratum in: J Neurol Neurosurg Psychiatry. 2003 May;74(5):694.

46.

Multiple sclerosis: Neurofilament light chain antibodies are correlated to cerebral atrophy.

Eikelenboom MJ, Petzold A, Lazeron RH, Silber E, Sharief M, Thompson EJ, Barkhof F, Giovannoni G, Polman CH, Uitdehaag BM.

Neurology. 2003 Jan 28;60(2):219-23.

PMID:
12552034
47.

Chemokine receptor expression on T cells is related to new lesion development in multiple sclerosis.

Eikelenboom MJ, Killestein J, Izeboud T, Kalkers NF, van Lier RA, Barkhof F, Uitdehaag BM, Polman CH.

J Neuroimmunol. 2002 Dec;133(1-2):225-32.

PMID:
12446027
48.

Markers for different glial cell responses in multiple sclerosis: clinical and pathological correlations.

Petzold A, Eikelenboom MJ, Gveric D, Keir G, Chapman M, Lazeron RH, Cuzner ML, Polman CH, Uitdehaag BM, Thompson EJ, Giovannoni G.

Brain. 2002 Jul;125(Pt 7):1462-73.

PMID:
12076997
49.

Comparisons of patient self-report, neurologic examination, and functional impairment in MS.

Hoogervorst EL, van Winsen LM, Eikelenboom MJ, Kalkers NF, Uitdehaag BM, Polman CH.

Neurology. 2001 Apr 10;56(7):934-7.

PMID:
11294932

Supplemental Content

Loading ...
Support Center